ONESOURCE

Onesource Specl Pharma L · ISIN INE013P01021 · Health Technology

Margin Trading Facility book for ONESOURCE across NSE and BSE. Free to use — no signup, no paywall. All figures in ₹ crore, derived from NSE and BSE public disclosures.

Funded value
₹68 Cr
as of 23 Apr 2026
Rank in book
#413
93 days tracked
Share of book
0.06%
of the whole NSE + BSE book
Peak funded
₹115 Cr
on 21 Apr 2026
NSE
₹67 Cr
BSE
₹1 Cr
Largest single-day addition
+₹22 Cr
on 16 Apr 2026
Largest single-day unwind
−₹33 Cr
on 23 Apr 2026

ONESOURCE — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole market book, and rank. Newest first.
DateCombinedDay ΔNSEBSE% of bookRank
23 Apr 2026₹68 Cr−₹33₹67₹10.06%413
22 Apr 2026₹101 Cr−₹14₹68₹320.09%294
21 Apr 2026₹115 Cr+₹13₹81₹340.10%258
20 Apr 2026₹102 Cr−₹1₹71₹300.09%293
17 Apr 2026₹103 Cr+₹4₹73₹300.09%288
16 Apr 2026₹99 Cr+₹22₹69₹300.09%293
15 Apr 2026₹77 Cr+₹1₹47₹300.07%359
13 Apr 2026₹77 Cr−₹8₹46₹300.07%356
10 Apr 2026₹84 Cr−₹1₹54₹300.08%329
09 Apr 2026₹85 Cr−₹1₹54₹300.08%325
08 Apr 2026₹86 Cr+₹2₹55₹300.08%322
07 Apr 2026₹84 Cr+₹1₹54₹300.08%326
06 Apr 2026₹83 Cr+₹0₹52₹300.08%327
02 Apr 2026₹83 Cr+₹0₹52₹300.08%329
01 Apr 2026₹83 Cr+₹1₹52₹300.07%330
30 Mar 2026₹82 Cr−₹1₹51₹300.07%334
27 Mar 2026₹83 Cr−₹1₹52₹300.07%332
25 Mar 2026₹84 Cr−₹1₹54₹300.08%327
24 Mar 2026₹85 Cr+₹1₹55₹300.08%328
23 Mar 2026₹85 Cr−₹1₹54₹300.07%330
20 Mar 2026₹85 Cr+₹4₹55₹300.07%329
19 Mar 2026₹82 Cr+₹3₹51₹300.07%344
18 Mar 2026₹79 Cr+₹1₹49₹300.07%350
17 Mar 2026₹78 Cr−₹1₹48₹300.07%354
16 Mar 2026₹79 Cr−₹1₹48₹300.07%351
13 Mar 2026₹80 Cr−₹0₹49₹300.07%354
12 Mar 2026₹80 Cr−₹0₹49₹300.07%354
11 Mar 2026₹80 Cr+₹0₹50₹300.07%350
10 Mar 2026₹80 Cr+₹22₹49₹300.07%350
09 Mar 2026₹58 Cr₹44₹140.05%462

IndiaMTF is an independent informational project. It is not a brokerage, is not affiliated with NSE, BSE or any SEBI-registered entity, and does not provide investment advice. Figures are derived from NSE and BSE public disclosures and may be revised or restated by the exchanges. Verify against the primary source before acting on anything here.